missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Physostigmine Salicylate, TRC
Specifications
Specifications
| Chemical Name or Material | Eserine Salicylate |
| CAS | 57-64-7 |
| Molecular Formula | C15 H21 N3 O2 . C7 H6 O3 |
| Quantity | 25 mg |
| Synonym | Physostigmine salicylate, (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate, Benzoic acid','2-hydroxy-','compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1) (ACI), Benzoic acid','2-hydroxy-','compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI), Benzoic acid','2-hydroxy-','compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (ZCI), Physostigmine salicylate (6CI), Physostigmine','monosalicylate (8CI), Pyrrolo[2,3-b]indol-5-ol','1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-','methylcarbamate (ester)','(3aS,8aR)-','mono(2-hydroxybenzoate) (salt) (9CI), Pyrrolo[2,3-b]indol-5-ol','1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-','methylcarbamate (ester)','(3aS-cis)-','mono(2-hydroxybenzoate) (salt) (ZCI), Salicylic acid','compd. with physostigmine (1:1) (8CI), (-)-Physostigmine salicylate, Eserine salicylate, Isopto Eserine |
| InChI Formula | InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1 |
| SMILES | CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1.OC(=O)c4ccccc4O |
| IUPAC Name | [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid |
| Molecular Weight (g/mol) | 413.47 |
| Formula Weight | 413.1951 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?